Skip to main content

483 Observations & Responding to FDA

US-unique

FDA Form 483 and the formal written response process are US-specific regulatory mechanisms.

What is a 483?​

FDA Form 483 (Inspectional Observations) is issued at the conclusion of an FDA inspection when an investigator observed conditions that may constitute violations of the FD&C Act or its implementing regulations. A 483 is not a final enforcement action — it is an opportunity for the manufacturer to correct issues before FDA takes further action.

Most common QMSR 483 observation areas (CDRH data)​

  1. CAPA (§ 820.100) — inadequate root cause analysis, ineffective CAPAs, no effectiveness checks
  2. Complaint files (§ 820.198) — complaints not evaluated for MDR reportability; incomplete complaint records
  3. Document/record controls — uncontrolled documents, outdated SOPs in use
  4. Design controls (§ 820.30) — missing design validation, incomplete DHF
  5. Nonconforming product (§ 820.90) — no documented disposition of nonconforming material
  6. Purchasing controls (§ 820.50) — inadequate supplier qualification
  7. Production/process controls — unvalidated processes, missing batch records

Writing an effective 483 response​

An effective 483 response:

  • Acknowledges each observation individually (do not lump observations together)
  • Does not argue with the observation (even if you disagree — address the substance)
  • Provides specific, time-bound corrective actions for each observation
  • Includes evidence of immediately completed corrections (attachments)
  • Proposes realistic but prompt timelines for longer-term corrective actions
  • Is submitted within 15 business days of receiving the 483

What happens after your response​

FDA reviews your response and determines whether:

  • The response is adequate — inspection closes with no further action
  • The response is inadequate — FDA issues a Warning Letter
  • Further inspection is warranted

Official resources​